Ma Private Wealth Amgen Inc Transaction History

Ma Private Wealth

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$233.58 - $259.14 $227,039 - $251,884	-972 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$221.91 - $258.6 $5,547 - $6,465	25 Added 2.64%	972 $242,000
Q4 2020 Jan 11, 2021	SELL	$216.38 - $257.67 $295,791 - $352,234	-1,367 Reduced 59.08%	947 $218,000
Q3 2020 Oct 26, 2020	BUY	$234.65 - $260.95 $234 - $260	1 Added 0.04%	2,314 $588,000
Q2 2020 Jul 14, 2020	BUY	$197.81 - $242.74 $395 - $485	2 Added 0.09%	2,313 $545,000

Q1 2020 Apr 16, 2020	SELL	$182.24 - $241.7 $24,602 - $32,629	-135 Reduced 5.52%	2,311 $468,000
Q4 2019 Jan 27, 2020	SELL	$189.21 - $243.2 $7,757 - $9,971	-41 Reduced 1.65%	2,446 $590,000
Q3 2019 Oct 10, 2019	SELL	$174.11 - $208.62 $83,921 - $100,554	-482 Reduced 16.23%	2,487 $481,000
Q2 2019 Jul 17, 2019	SELL	$166.7 - $195.41 $31,006 - $36,346	-186 Reduced 5.9%	2,969 $547,000
Q1 2019 Apr 24, 2019	SELL	$180.87 - $203.88 $131,311 - $148,016	-726 Reduced 18.71%	3,155 $599,000
Q4 2018 Feb 08, 2019	BUY	$178.4 - $208.25 $692,370 - $808,218	3,881 New	3,881 $756,000

2,933

401M

6.59M

6.6M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Ma Private Wealth, based on Form 13F filings with the SEC.

Stay updated on Ma Private Wealth with notifications on news.